-
1
An integrated valuation model for payer and investor
Published 2022-12-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
2
Approaches to manage ‘affordability’ of high budget impact medicines in key EU countries
Published 2018-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
3
An Inclusive Civil Society Dialogue for Successful Implementation of the EU HTA Regulation: Call to Action to Ensure Appropriate Involvement of Stakeholders and Collaborators
Published 2024-03-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
4
Budget impact analysis for avatrombopag in the treatment of chronic primary immune thrombocytopenia in adult patients refractory to other treatments
Published 2023-12-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
5
The role of stakeholder involvement in the evolving EU HTA process: Insights generated through the European Access Academy’s multi-stakeholder pre-convention questionnaire
Published 2023-12-01“…Journal of Market Access & Health Policy…”
Get full text
Article -
6
Pricing of orphan drugs in oncology and rare diseases
Published 2020-01-01“…Journal of Market Access & Health Policy…”
Get full text
Article